RE: Back to the starting point28 Sep 2021 14:25
As part of its expansion in private testing, the Company has also signed a supply contract initially for genesig® COVID-19 products with Excalibur Healthcare Services, who have invested in new laboratory services in Cambridge, UK, to support COVID-19 testing of private clients.
June Rns
This clinical trial expertise is a key requirement of the new IVD-R regulation being introduced in May 2022. The team consists of more than 40 qualified people dedicated to designing, running and reporting on clinical trials in the UK, Europe, US and Latin America. During the year, this team completed over a dozen product validations. To date, Novacyt has run six clinical trials in support of its product development and is able to assess new products (internal and external) rapidly and thoroughly through this operation. This, coupled to our bioinformatics and surveillance functionality, will enable the Group to remain at the forefront of new diagnostic innovation as part of our growth plans.
There's plenty for the company to report on for example why have 3/4/5 pieces of news in the one Rns they don't arrive at the same time. On aim where companies Rns a director reversing into a parking space we save it up and save it up. Sure we have NDA's at times but there is loads of news here constantly they just choose(wrongly) to not report it.